Pharmaceuticals for Intra-arterial Therapy

Aalpen A. Patel; Jeffery A. Solomon; Michael C. Soulen

doi:10.1055/s-2005-871868

Seminars in Interventional Radiology, Inhaltsverzeichnis

Semin intervent Radiol 2005; 22(2): 130-138
DOI: 10.1055/s-2005-871868

Pharmaceuticals for Intra-arterial Therapy

Aalpen A. Patel¹ , Jeffery A. Solomon¹ , Michael C. Soulen¹

¹Department of Radiology, Interventional Radiology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania

Abstract

ABSTRACT

Clinical pharmacology may be defined as the branch of medicine concerned with the therapeutic agents used in the prevention, treatment, and control of disease. Pharmaceuticals are the specific agents used to combat disease. Hence, many of the agents used by the interventionalist may be considered pharmaceuticals. Safe and effective use of these therapeutics requires understanding of vascular anatomy and disease pathology, proper technique, and knowledge of the therapeutic agents. This article reviews many of the agents available and some that are on the horizon. The future of transarterial therapies is bright and holds many promises.

KEYWORDS

Intra-arterial therapy - embolization - pharmembolics - pharmaceuticals - cellular transplantation

Volltext

Referenzen

REFERENCES

1 Stedman's Medical Dictionary. 25th ed. Baltimore; Williams & Wilkins 1990: 1177
2 Dawbarn R HM. The starvation operation for malignancy in the external carotid area. JAMA. 1904; 43 792-795
3 Patel A A, Soulen M C. Agents for small vessel/tissue embolization and transcatheter tissue ablation: current status and the future. In: Baum SA, Pentecost MJ Interventional Radiology. 2nd ed. Philadelphia; Lippincott Williams and Wilkins 2005: 169-175 In press
4 Levin D C, Beckmann C F, Hillman B. Experimental determination of flow patterns of gelfoam emboli: safety implications. AJR Am J Roentgenol. 1980; 134 525-528
5 Ohyama T, Nishide T, Iwata H et al.. Immobilization of basic fibroblast growth factor on a platinum microcoil to enhance tissue organization and in intracranial aneurysms. J Neurosurg. 2005; 102 109-115
6 Marx W E, Cloft H J, Helm G A et al.. Endovascular treatment of experimental aneurysms by use of biologically modified embolic devices: coil-mediated intraaneurysmal delivery of fibroblast tissue allografts. AJNR Am J Neuroradiol. 2001; 22 323-333
7 Murayama Y, Vinuela F, Suzuki Y et al.. Development of the biologically active Guglielmi detachable coil for the treatment of cerebral aneurysms. Part II: an experimental study in a swine aneurysm model. AJNR Am J Neuroradiol. 1999; 20 1992-1999
8 Murayama Y, Tateshima S, Gonzalez N et al.. Matrix and bioabsorbable polymeric coils accelerate healing of intracranial aneurysms: long-term experimental study. Stroke. 2003; 34 2031-2037
9 Ribourtout E, Raymond J. Gene therapy and endovascular treatment of intracranial aneurysms. Stroke. 2004; 35 786-793
10 Haisma H J, Grill J, Curiel D T et al.. Targeting of adenoviral vectors through a bispecific single-chain antibody. Cancer Gene Ther. 2000; 7 901-904
11 Klugherz B D, Song C, DeFelice S et al.. Gene delivery to pig coronary arteries from stents carrying antibody-tethered adenovirus. Hum Gene Ther. 2002; 13 443-454
12 Abrahams J M, Song C, DeFelice S, Grady M S, Diamond S L, Levy R J. Endovascular microcoil gene delivery using immobilized anti-adenovirus antibody for vector tethering. Stroke. 2002; 33 1376-1382
13 Barth K H, Strandberg J D, White Jr R I. Long-term follow-up of transcatheter embolization with autologous clot, Oxycel, and Gelfoam in domestic swine. Invest Radiol. 1977; 12 273-280
14 Barbolt T A, Odin M, Leger M et al.. Pre-clinical subdural tissue reaction and absorption study of absorbable hemostatic devices. Neurol Res. 2001; 23 537-542
15 Kaufman S L, Strandberg J D, Barth K L, White Jr R I. Transcatheter embolization with microfibrillar collagen in swine. Invest Radiol. 1978; 13 200-204
16 Daniels J R, Kerlan R K, Dodds L et al.. Peripheral hepatic arterial embolization with crosslinked collagen fibers. Invest Radiol. 1987; 22 126-131
17 Sniderman K W, Sos T A, Alonso D R. Transcatheter embolization with Gelfoam and Avitene: the effect of Sotradecol on the duration of arterial occlusion. Invest Radiol. 1981; 16 501-507
18 Tellez C, Benson III A B, Lyster M T et al.. Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature. Cancer. 1998; 82 1250-1259
19 Aigner K R. Intra-arterial infusion: overview and novel approaches. Semin Surg Oncol. 1998; 14 248-253
20 Kumada T, Nakano S, Sone Y et al.. Clinical effectiveness of degradable starch microspheres (DSM) in patients with liver cancer. Gan To Kagaku Ryoho. 1999; 26 1678-1683
21 Civalleri D, Esposito M, Fulco R A et al.. Liver and tumor uptake and plasma pharmacokinetics of arterial cisplatin administered with and without starch microspheres in patients with liver metastases. Cancer. 1991; 68 988-994
22 Hakansson L, Hakansson A, Morales O, Thorelius L, Warfving T. Spherex (degradable starch microspheres) chemo-occlusion-enhancement of tumor drug concentration and therapeutic efficacy: an overview. Semin Oncol. 1997; 24(suppl 6) S6-S109
23 Castañeda-Zuñiga W R, Sanchez R, Amplatz K. Experimental observations on short- and long-term effects of arterial occlusion with Ivalon. Radiology. 1978; 126 783-785
24 Bandi R, Shetty P C, Sharma R P et al.. Superselective arterial embolization for the treatment of lower gastrointestinal hemorrhage. J Vasc Interv Radiol. 2001; 12 1399-1405
25 www.bostonscientific.com
26 www.biocompatibles.com
27 www.biospheremed.com
28 Laurent A, Beaujeux R, Wassef M et al.. Trisacryl gelatin microspheres for therapeutic embolization, I: development and in vitro evaluation. AJNR Am J Neuroradiol. 1996; 17 533-540
29 Beaujeux R, Laurent A, Wassef M et al.. Trisacryl gelatin microspheres for therapeutic embolization, II: preliminary clinical evaluation in tumors and arteriovenous malformation. AJNR Am J Neuroradiol. 1996; 17 541-548
30 Shapiro A MJ, Lakey J RT, Ryan E A et al.. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med. 2000; 343 230-238
31 Soulen M C, Faykus M H, Shlansky-Goldberg R D et al.. Elective embolization for prevention of hemorrhage from renal angiomyolipomas. J Vasc Interv Radiol. 1994; 5 587-591
32 Wright K C, Loh G, Wallace S et al.. Experimental evaluation of ethanol-ethiodol for transcatheter renal embolization. Cardiovasc Intervent Radiol. 1990; 13 309-313
33 Pollak J S, White R I. The use of cyanoacrylate adhesives in peripheral embolization. J Vasc Interv Radiol. 2001; 12 907-913
34 www.jnj.com/news/jnj_news/20020307_1752.htm
35 Hunter D W, Casteñeda-Zuñiga W R, Coleman C C et al.. Spermatic vein embolization with hot contrast medium or detachable balloons. Semin Interv Radiol. 1984; 1 163-166
36 http://www.sirtex.com/
37 Gray B N, Van Hazel G, Anderson J et al.. Randomised phase II trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone on advanced colorectal hepatic metastases. Presented at the 2002 meeting of the American Society of Clinical Oncology (ASCO). Abstract number 599 (100474)
38 Gray B, Van Hazel G, Hope M et al.. Randomised trial of SIR-Spheres plus chemotherapy versus chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Ann Oncol. 2001; 12 1711-1720
39 www.TheraSphere.com
40 Moroz P, Jones S K, Gray B N. Tumour response to arterial embolization hyperthermia and direct injection hyperthermia in a rabbit liver tumour model. J Surg Oncol. 2002; 80 149-156
41 Johnson J. Magnetic Targeted Carriers: An Innovative Drug Delivery Technology; Spring 2002 (Premier Issue). Available at: www.MagneticsMagazine.com

Aalpen A PatelM.D.

Department of Radiology, Interventional Radiology, Hospital of the University of Pennsylvania

3400 Spruce Street, Philadelphia, PA 19104